Staci Kearney, Elevation Strategic Consulting

 

 

Staci Kearney PhD is the founder and CEO of Elevation Strategic Consulting, a firm that provides regulatory assistance to digital pathology companies. In May 2024, the FDA ruled that Laboratory Developed Tests (LDTs) will be regulated as medical devices with FDA oversight in the coming years. Staci joins for a special episode to break down the timeline for vendors to be compliant with the new rule and implications for digital pathology companies and laboratories.

 

[DPA Webinar] Regulatory Changes Unpacked: Expert Insights into the FDA's Oversight of LDTs in Digital Pathology

Laboratory Developed Tests-Frequently Asked Questions-FDA


 

 

Please log in to your DPA profile to submit comments

 

RELATED CONTENT

PODCAST

Lewis Hassell, University of Oklahoma Health Sciences...

Season 2 Episode 7

LISTEN NOW

PODCAST

Esther Abels, Visiopharm; 2021 DPA President-Elect

Season 1 Episode 8

LISTEN NOW

PODCAST

Liron Pantanowitz, 2023 DPA President

Season 3 Episode 11

LISTEN NOW